Your browser doesn't support javascript.
loading
Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy.
Mullen, Kevin D; Sanyal, Arun J; Bass, Nathan M; Poordad, Fred F; Sheikh, Muhammad Y; Frederick, R Todd; Bortey, Enoch; Forbes, William P.
Afiliação
  • Mullen KD; Case Western Reserve University School of Medicine, Cleveland, Ohio. Electronic address: kdm@case.edu.
  • Sanyal AJ; Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, Richmond, Virginia.
  • Bass NM; Divison of Gastroenterology, University of California San Francisco, San Francisco, California.
  • Poordad FF; The Texas Liver Institute/University of Texas Health Science Center, San Antonio, Texas.
  • Sheikh MY; University of California San Francisco Fresno Medical Education Program, Fresno, California.
  • Frederick RT; Division of Hepatology, California Pacific Medical Center, San Francisco, California.
  • Bortey E; Salix Pharmaceuticals, Inc, Raleigh, North Carolina.
  • Forbes WP; Salix Pharmaceuticals, Inc, Raleigh, North Carolina.
Clin Gastroenterol Hepatol ; 12(8): 1390-7.e2, 2014 Aug.
Article em En | MEDLINE | ID: mdl-24365449
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rifamicinas / Fármacos Gastrointestinais / Encefalopatia Hepática Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rifamicinas / Fármacos Gastrointestinais / Encefalopatia Hepática Idioma: En Ano de publicação: 2014 Tipo de documento: Article